Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspylori: Prevention of Aspirin-Induced Gastric Lesions in H. Pylori Infected Patients
NCT00713947Phase 4Withdrawn
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pantoprazole, amoxicillin, clarithromycin, metronidazole in Gastric lesions, Helicobacter pylori infection, sponsored by Assistance publique - Hôpitaux de Paris. Planned start Apr 2008; status: withdrawn.
02
Drugs
pantoprazoleamoxicillinclarithromycinmetronidazole
03
Conditions
Gastric lesionsHelicobacter pylori infection
Beyond the preview
Go deeper on NCT00713947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00713947.